Kencur's Antimicrobial Properties and Oral Wound-Healing Research
Two genuinely separate bodies of research sit under this page's title. One is old and thin: scattered antibacterial screening of kencur rhizome against a handful of bacteria, going back to 2003. The other is recent, concentrated, and almost entirely unmentioned on the main Kencur page: a 2022–2024 research program isolating specific compounds from kencur rhizome and formulating them into mouth gels for oral ulcers and stomatitis, with real animal and cell-culture efficacy data behind it — including one study where a kencur extract outperformed a standard steroid comparator. This page also documents a case worth reading carefully: a paper whose title promises antimicrobial activity for kencur but whose own results credit two different plants tested alongside it.
Table of Contents
- Two Separate Bodies of Evidence Under One Roof
- The Direct Antibacterial Testing
- A Paper Whose Title Oversells Kencur's Role
- Computational Docking Is Not a Laboratory Result
- The Oral Mucosal Ulcer Research Program: Isopimarane Diterpenes
- From Compound to Product: Formulating a Mucoadhesive Gel
- An Animal Efficacy Trial Against a Steroid Comparator
- An Older, Classic Wound-Healing Study
- What "Antimicrobial" Does Not Mean for a Kitchen Spice
- Cooking Versus Products: What the Evidence Covers
- Key Research Papers
- Connections
- Featured Videos
Two Separate Bodies of Evidence Under One Roof
It is worth separating these two literatures from the start, because conflating them would overstate both. The first is direct antibacterial and antifungal screening: testing whether a kencur extract, in a dish, slows the growth of specific bacteria. This work is real but modest — a handful of studies, several decades old, usually testing kencur as one of several plants in a broader screen rather than as the focus. The second is a genuinely active, recent, and much more developed program: isolating specific anti-inflammatory and wound-healing compounds from kencur rhizome and building them into topical mouth-gel products for oral ulcers, complete with cell-culture efficacy testing, animal models, and pharmaceutical formulation and stability data. The second body of work is where most of the substance in this article lives.
The Direct Antibacterial Testing
Three studies test kencur rhizome or its named compounds directly against bacteria:
- Wang and colleagues (2025) ran the most rigorous of the three. Using a purpose-built capillary electrophoresis method, they separated and quantified kaempferide (a flavonoid genuinely present in kencur, not merely sharing a similar-sounding name) directly from rhizome extract, then tested both the isolated compound and the whole extract against three foodborne bacteria: Escherichia coli, Staphylococcus aureus, and Vibrio parahaemolyticus. Both the isolated kaempferide and the whole kencur extract inhibited bacterial growth, with stronger effect against the two land-associated bacteria (E. coli, S. aureus) than against the marine bacterium. This is a meaningful result specifically because the researchers confirmed kaempferide's presence in kencur extract by direct measurement before testing it — the same standard of evidence that matters throughout this Benefits set, and one that a flavonoid-based claim does not always meet.
- Sini and Malathy (2005) screened root extracts (hexane, chloroform, and aqueous) of six traditional medicinal plants, including kencur, against two bacteria (Bacillus pumilis and E. coli) by disc diffusion. The available record of this study is a brief abstract without a kencur-specific zone-of-inhibition or minimum inhibitory concentration (MIC) value reported separately from the other five plants, so it can be cited honestly only as "kencur was one of six roots showing antibacterial activity in this screen," not as a specific, quantified kencur result.
- Mekseepralard and colleagues (2010) tested a traditional Thai remedy for aphthous ulcers (canker sores) built from four plants — oak gall (Quercus infectoria), kencur, Coptis chinensis, and licorice — both as the combined traditional powder and as individual plant extracts, against a panel of bacteria and Candida albicans. The strongest individual results in this study belonged to the other two plants: oak gall against Staphylococcus aureus (minimum inhibitory concentration 0.41 mg/mL) and Coptis chinensis against Candida albicans (minimum inhibitory concentration 6.25 mg/mL). The combined traditional powder showed activity comparable to the individual extracts, but the paper does not isolate what fraction of that combined effect, if any, traces specifically to kencur. The same study found that incorporating the powder into a gel formulation resulted in the loss of almost all of its antimicrobial activity — a point that matters for any home-made gel or paste. Worth reporting honestly in the other direction too: this same study found that kencur was the one plant of the four that did not show good antioxidant activity in its own antioxidant assay — a negative finding for kencur specifically, in a study that is otherwise mixed evidence for its antimicrobial contribution.
A Paper Whose Title Oversells Kencur's Role
One 2024 paper is worth discussing at length precisely because a reader relying on its title alone would draw the wrong conclusion about kencur. Amil and colleagues published "Antimicrobial and Antiproliferative Effects of Zingiberaceae Oils: A Natural Solution for Oral Health" — a title that names the whole ginger family, ginger's botanical family, as delivering antimicrobial benefit for oral health. Kencur was indeed one of four Zingiberaceae species tested (alongside three Curcuma species: mango ginger, Javanese turmeric, and Curcuma aeruginosa).
Reading the actual results, not just the title: the significant antibacterial activity the study reports against oral bacteria — Streptococcus mitis, S. sanguinis, and S. mutans, the primary cavity-causing species — belongs specifically to Javanese turmeric oil and mango ginger oil. Kencur's own essential oil is not named among the extracts producing meaningful inhibition zones in the results. In the composition analysis, the abstract lists the main constituent of each of the four oils (beta-myrcene, ethyl cinnamate, beta-curcumene and alloaromadendrene) without crediting kencur's oil with an antibacterial result — for kencur, the paper is a chemical-profiling data point, not a demonstrated antibacterial contribution.
This matters as more than a technicality. If this study were cited casually as "Zingiberaceae oils, including kencur, show antimicrobial effects for oral health," it would be crediting kencur with a result that, on the paper's own data, belongs to two different plants in the same family tested alongside it — the same kind of substitution error that recurs across herbal-evidence writing generally, just one genus-level rather than one species-level. It is included here, rather than silently dropped, precisely so a reader who encounters this paper's title elsewhere has the actual result to check it against.
Computational Docking Is Not a Laboratory Result
One further antimicrobial-adjacent paper deserves a clear evidence-tier label rather than being folded in with the laboratory studies above. A 2025 study by Sharma and colleagues ran in-silico (computer-simulated) molecular docking of two kencur essential-oil compounds, gamma-elemene and caryophyllene, against two Staphylococcus aureus biofilm-forming proteins, CrtM and SarA, predicting favorable binding based on modeled molecular geometry and energy calculations.
This is the weakest evidence tier that appears anywhere in this Benefits set, and it is worth explaining exactly why: a docking study never touches a live bacterium, a cell culture, or an animal. It is a prediction, generated entirely inside software, about whether a molecule's three-dimensional shape is compatible with a protein's binding pocket. Docking studies are useful for generating hypotheses that then get tested in an actual dish or animal — they are not themselves evidence that the predicted interaction produces any real biological effect, and a meaningful fraction of computationally-promising docking predictions fail when actually tested in the wet lab. No such follow-up laboratory test of these two compounds against live S. aureus biofilm has yet been published.
The Oral Mucosal Ulcer Research Program: Isopimarane Diterpenes
This is the real center of gravity for this page: a coherent, multi-year research program isolating specific diterpene compounds from kencur rhizome and testing their wound-healing and anti-inflammatory activity for oral mucosal ulcers — the mouth sores and stomatitis that affect roughly a quarter of the global population at some point, including as a side effect of chemotherapy and radiotherapy.
- Sudsai and colleagues (2022) isolated an isopimarane diterpene, 6β-acetoxysandaracopimaradiene-1α,9α-diol (labeled KG6), from kencur rhizome and formulated it into gels at three concentrations. Tested in human dermal fibroblast (HDF) cell culture — laboratory cells, not a person — the 0.25% gel increased cell viability to 102.8% and produced 91.9% cell migration (a standard proxy for wound-closure speed), both slightly ahead of an Aloe vera gel comparator tested the same way (96.2% viability, 78.4% migration). The gel also suppressed nitric oxide release (anti-inflammatory activity) and protected fibroblasts against induced oxidative stress. The 0.25% gel also increased collagen content in the fibroblast cells.
- Pathan, Iadnut, and Tewtrakul (2024) isolated a second, structurally related compound, kaempulchraol K (KG2), and ran a similar formulation and testing sequence: anti-inflammatory activity in macrophage cell culture (NO-inhibition IC50 = 66.8 µM) and wound-healing activity in human gingival fibroblasts (HGF). The compound itself at 3 µM induced the highest cell migration on day 3 (90.2 ± 2.4%); all three mouth-gel strengths (0.10%, 0.25% and 0.50% w/w) enhanced cell migration on day 3 more than the positive controls, and the 0.50% gel gave the highest cell viability (128.6%).
- Iadnut, Sae-Lee, and Tewtrakul (2024, a follow-up to the Sudsai 2022 work) returned to the same KG6 compound with a more detailed formulation and stability study, this time in human gingival fibroblast cells (HGF-1) specifically — the cell type actually relevant to a mouth-gel product — and benchmarked against a commercial Thai mouth gel as the positive control. The 0.50% KG6 mouth gel's anti-inflammatory effect (nitric oxide inhibition, IC50 557.7 µg/ml) was comparable to that of the commercial gel, and all KG6 gel strengths exceeded it on cell migration (94.7–98.9% versus 73.5% for the commercial gel), while also showing a genuine antioxidant effect under induced oxidative stress.
All three studies are in-vitro cell-culture work, not animal or human trials; the cell-culture results are real, specific, and reasonably consistent across the three related studies.
From Compound to Product: Formulating a Mucoadhesive Gel
A companion 2024 study by Wahyuni and colleagues addressed a more practical question: not whether kencur's compounds are biologically active, but whether kencur extract can actually be formulated into a stable, usable oral-care gel. Using the whole ethanolic rhizome extract, they tested several gelling agents and found a carbomer gel base (carbomer 934) produced the most physically stable preparation across 14 days of storage, outperforming three commercial oral-care gel products on stability testing. HPLC identified EPMC in the carbomer gels containing 5% and 10% extract, which had polyphenol levels of 1201.2557 mg/kg and 1849.1506 mg/kg respectively. A 30-person sensory panel rated the 5% extract formulation the most acceptable for taste, smell, and feel.
This is a real and useful pharmaceutical-formulation result — it establishes that a kencur-based oral gel is technically feasible and tolerated by a small human panel for basic sensory acceptance — but it is not a clinical efficacy trial. A sensory-acceptance panel measures whether people find a product pleasant to use, not whether it heals an ulcer faster than a placebo. The same research group's own earlier paper, discussed next, states plainly that formal human clinical trials of this material have not yet been conducted.
An Animal Efficacy Trial Against a Steroid Comparator
The strongest single efficacy result in this entire article comes from Wahyuni and colleagues' earlier 2022 study, and it deserves to be reported clearly rather than buried among the cell-culture work above, because it is a genuine animal efficacy trial with a real drug comparator, not just a cell-culture activity assay.
Thirty-five rats were divided into seven groups: untreated normal controls, untreated ulcer controls, a group treated with triamcinolone acetonide (the actual conventional steroid therapy used clinically for oral mucosal ulceration), and four groups treated with different concentrations of ethanol extract of kencur rhizome (EEKG), after all ulcer groups had oral mucosal ulcers induced with 70% acetic acid. Recovery was measured by ulcer-area percentage, a clinical inflammation sign score, and microscopic histopathology.
The 0.5% EEKG dose was more effective than the triamcinolone acetonide comparator on percent ulcer-area recovery and inflammation-sign score, and doses of 0.5–2% EEKG reduced the histopathological damage score. The study's own stated conclusion was appropriately cautious: that kencur "is very potential to be developed as a prospective phytopharmaceutical for the treatment of oral mucosal ulceration in human after clinical trials" — the researchers' own words make clear that no such trial had yet happened. One rat study, however striking the steroid comparison, is not equivalent to a clinical trial, and beating one specific steroid at one specific dose in one specific animal model is not the same claim as "as effective as steroid treatment" in general use.
A 2024 follow-up by the same research group used the same seven-group rat design (normal, untreated, triamcinolone acetonide, and four extract strengths of 0.5%, 1%, 2% and 4%) and found that the ethanol extract of kencur rhizome lowered the expression of two inflammation signals, COX-2 and NF-kappaB-p65, in the rats' tongue tissue. In safety tests the extract caused no irritation in the hen's egg membrane test (HET-CAM), and a single 200 mg/kg application on the skin of albino rabbits caused mild irritation without redness (erythema) or swelling (edema), with no significant body-weight change, no toxic effects on the organs and no abnormalities in the blood profile. Like the 2022 study, this is animal and laboratory work, not a human trial.
An Older, Classic Wound-Healing Study
Predating the Thai oral-ulcer research program by over a decade, Tara Shanbhag and colleagues (2006) tested alcoholic kencur extract in three separate classic wound-healing models in Wistar rats — incision wounds (measuring breaking strength), excision wounds (measuring the rate of wound contraction and re-epithelialization), and dead-space wounds (measuring granulation tissue formation) — both alone and alongside dexamethasone, a steroid known to impair wound healing as a side effect.
Kencur extract alone significantly shortened the time needed for epithelialization and increased wound contraction, though the contraction difference was significant only on day 16. More interesting mechanistically: when co-administered with dexamethasone, kencur extract significantly reversed dexamethasone's wound-healing-impairing effect on all three measures. That reversal-of-a-known-drug-effect design is a more informative test than a simple untreated-versus-treated comparison, because it demonstrates the extract is doing something specific to the wound-healing process rather than merely reflecting some general difference between animal groups. It remains, like everything else on this page, animal data.
What "Antimicrobial" Does Not Mean for a Kitchen Spice
It is worth doing the arithmetic on what these minimum inhibitory concentration (MIC) values actually require, because "antimicrobial activity" sounds like a stronger claim in prose than the numbers support in practice. The strongest minimum inhibitory concentration reported anywhere in this article — kencur's 25 micrograms per milliliter against H. pylori, discussed in full on the digestive health page — describes a concentration of purified extract bathing bacteria directly in a laboratory dish. Reaching an equivalent concentration throughout, say, the stomach lining of a person eating a few grams of kencur in a peanut-sauce dressing would require an amount of extracted, concentrated active compound many times beyond what a culinary serving delivers, before accounting for digestion, absorption, and the fact that a kitchen preparation is mostly water and rice, not concentrated rhizome extract. None of the antibacterial or antifungal findings in this article were designed to establish, or do establish, a dose at which eating kencur meaningfully changes the bacterial population anywhere in a person's body.
Cooking Versus Products: What the Evidence Covers
Kencur used as a kitchen spice — in sambal, peanut sauce, or the traditional sha jiang dipping sauce — carries none of the concentration needed for any antimicrobial or wound-healing effect described above, and the studies on this page raise no safety concern about culinary amounts; it is simply flavor, with a long culinary track record. A homemade kencur poultice or topical paste for a minor scrape has weak, mostly indirect support (the older wound-healing rat data, plus the general safety profile) and low realistic risk for intact skin. Deep, infected or non-healing wounds are outside anything these studies tested; spreading redness, pus or fever around a wound are signs of infection that clinics treat as urgent. A commercial kencur-based mouth gel, if one becomes available outside the research literature, sits on genuinely the most developed evidence in this article — real isolated compounds, real cell-culture and animal efficacy results — but still short of the human clinical trial its own researchers say is the next necessary step; no human trial yet supports marketing claims for any such product.
Key Research Papers
- Wahyuni IS, Sufiawati I, Nittayananta W, Levita J. Anti-inflammatory activity and wound healing effect of Kaempferia galanga L. rhizome on the chemical-induced oral mucosal ulcer in Wistar rats. Journal of Inflammation Research, 2022;15:2281–2294. — PubMed PMID: 35422649
- Wahyuni IS, Sufiawati I, Shafuria A, Nittayananta W, Levita J. Formulation and evaluation of mucoadhesive oral care gel containing Kaempferia galanga extract. Pharmaceutics, 2024;16(3):421. — PubMed PMID: 38543315
- Pathan N, Iadnut A, Tewtrakul S. Anti-inflammatory and wound healing effects of mouth gel containing kaempulchraol K from Kaempferia galanga rhizomes. Journal of Ethnopharmacology, 2024;324:117762. — PubMed PMID: 38219883
- Iadnut A, Sae-Lee T, Tewtrakul S. Wound healing potential of mouth gel containing isopimarane diterpene from Kaempferia galanga rhizomes for treatment of oral stomatitis. PeerJ, 2024;12:e18716. — PubMed PMID: 39713130
- Sudsai T, Tungcharoen P, Tewtrakul S. Wound healing properties of pharmaceutical gel containing isopimarane diterpene isolated from Kaempferia galanga L. Journal of Ethnopharmacology, 2022;289:115052. — PubMed PMID: 35101569
- Tara Shanbhag V, Chandrakala S, Sachidananda A, Kurady BL, Smita S, Ganesh S. Wound healing activity of alcoholic extract of Kaempferia galanga in Wistar rats. Indian Journal of Physiology and Pharmacology, 2006;50(4):384–390. — PubMed PMID: 17402268
- Wang Q, Ye J, Wang W. Study of bacteriostasis of kaempferide on foodborne pathogenic bacteria by indirect determination of capillary electrophoresis. Electrophoresis, 2025;46(19):1471–1478. — PubMed PMID: 40916637
- Mekseepralard C, Kamkaen N, Wilkinson JM. Antimicrobial and antioxidant activities of traditional Thai herbal remedies for aphthous ulcers. Phytotherapy Research, 2010;24(10):1514–1519. — PubMed PMID: 20878703
- Sini S, Malathy NS. Antimicrobial properties of roots of medicinal plants. Ancient Science of Life, 2005;25(2):62–65. — PubMed PMID: 22557193
- Amil MA, Rahman SNSA, Yap LF, et al. Antimicrobial and antiproliferative effects of Zingiberaceae oils: a natural solution for oral health (positive results attributable to Curcuma xanthorrhiza and C. mangga, not Kaempferia galanga). Chemistry & Biodiversity, 2024;21(3):e202301836. — PubMed PMID: 38253795
- Sharma V, Gogoi B, Borah SN, Ghosh A, Mazumdar A, Kalita RD. In-silico molecular docking and molecular dynamic simulation of γ-elemene and caryophyllene identified from the essential oil of Kaempferia galanga L. against biofilm forming proteins, CrtM and SarA of Staphylococcus aureus (computational prediction only, no laboratory confirmation). Journal of Biomolecular Structure and Dynamics, 2025;43(15):8357–8369. — PubMed PMID: 38321959
- Wahyuni IS, Diina TR, Salsabila AS, Khairinisa MA, Sufiawati I, Levita J, Rosdianto AM, Nittayananta W. Kaempferia galanga L. alleviates the expression of COX-2 and NF-kappaB-p65 in the oral mucosa ulcer of Wistar rats and exhibits no irritation toward the vascular membrane of chicken eggs and the skin of albino rabbits. Heliyon, 2024;10(16):e35827. — PubMed PMID: 39224366